Ever Source Wealth Advisors, LLC Amylyx Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 25 shares of AMLX stock, worth $99. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$99% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMLX
# of Institutions
140Shares Held
48.9MCall Options Held
281KPut Options Held
438K-
Perceptive Advisors LLC New York, NY6.77MShares$27 Million0.85% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA4.64MShares$18.5 Million2.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$10.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$10.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.43MShares$9.66 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $233M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...